REGISTER! – Texas Heart Institute Cardiac Society Symposium
The Texas Heart Institute Cardiac Society Symposium is held every year in May, at the end of the academic season. This year’s meeting will be May 11, 2018.
The cardiovascular field is rapidly evolving. Within the last decade there has been tremendous advances in the field of transcatheter therapies to treat arrhythmia and valvular, congenital, coronary and peripheral vascular diseases. In the same time period we have witnessed the introduction of novel antithrombotic therapies for atrial fibrillation and deep venous thrombosis. Additionally, advances in the field of echocardiography, cardiac CT and MRI have improved risk assessments and become essential components of procedural planning for percutaneous interventions, particularly for structural heart disease.
This symposium will explore the management and treatment of patients with structural, coronary, peripheral vascular, electrophysiologic diseases, venous disease, and risk factor management. The program includes advanced lectures, interactive and dynamic case presentations, debates from leaders in each field and the opportunity to interact with leaders in an intimate meeting format.
Given the increasing complexity of our specialty and the focused scope of our medical meetings, physicians in training, physicians in practice and all associated health care personnel can find it difficult to participate in educational activities that cover the breath of cardiovascular medicine. This meeting hopes to provide members of the Texas Heart Institute Cardiac Society and other health professionals involved in cardiovascular care with an educational experience that is comprehensive and yet concentrated in a practical, one-day format. The meeting also provides a forum for exchange of ideas.
Our audience for this continuing medical education activity will include cardiologists and researchers with an interest in cardiovascular disease, especially arrhythmias and valvular, congenital, coronary and peripheral vascular diseases. Participants to include physicians, fellows, residents, physician assistants, pharmacists, nurses / nurse practitioners and medical students.